Biomarker Correlates of Hypoxia in Metastatic Melanoma

NCT02061007 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped no accrual

Conditions

Melanoma
Skin Cancer

Interventions

DRUG: Pimonidazole hydrochloride (Hypoxyprobe™-1)
DRUG: Optional 18F-FMISO PET scan (18F-fluoromisonidazole)
PROCEDURE: Surgical Resection of Melanoma Metastases

Sponsor

H. Lee Moffitt Cancer Center and Research Institute